Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone for exogenous allergic alveolitis in childhood
2013-003689-15Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Feb 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypersensitivity pneumonitis (HP) comparing Prednisolone with Placebo (2 arms). Primary endpoint: Relative change in primary disease outcome from baseline to month 6 (prednisolone vs placebo). Started Feb 2014; status: completed.
02
Drugs
prednisolone
03
Conditions
hypersensitivity pneumonitis (HP)
Beyond the preview
Go deeper on 2013-003689-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003689-15.